Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC + R-ICE in Relapsed/Refractory DLBCL
NCT00829205Phase 2Withdrawn
- Sponsor
- Cancer Research UK
- Start
- Jan 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Methylselenocysteine in diffuse large B-cell lymphoma (DLBCL), sponsored by Cancer Research UK. Planned start Jan 2009; status: withdrawn.
02
Drugs
Methylselenocysteine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00829205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00829205.